Search for: "v. Teva Pharmaceuticals USA, Inc."
Results 21 - 40
of 440
Sort by Relevance
|
Sort by Date
12 Jun 2023, 1:09 pm
In Matrixx Initiatives, Inc. v. [read post]
11 Jun 2023, 8:17 pm
Teva Pharmaceuticals USA, Inc. [read post]
18 May 2023, 8:01 am
Most surprisingly to me, the court denied review in Teva Pharmaceuticals USA, Inc. v. [read post]
17 May 2023, 8:53 am
Defendant Teva Pharmaceuticals USA, Inc. [read post]
17 May 2023, 8:53 am
Defendant Teva Pharmaceuticals USA, Inc. [read post]
17 May 2023, 8:53 am
Defendant Teva Pharmaceuticals USA, Inc. [read post]
15 May 2023, 7:21 am
” This petition has a minimal likelihood of being granted. = = = = The court also denied certiorari in the skinny-label FDA-Patent case of Teva Pharmaceuticals USA, Inc. v. [read post]
11 May 2023, 1:16 pm
New Relists Teva Pharmaceuticals USA, Inc. v. [read post]
1 May 2023, 10:11 am
Teva Pharmaceuticals USA, Inc. v. [read post]
26 Sep 2022, 4:49 am
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
23 Aug 2022, 8:52 pm
Lee (2016)"; and "Teva Pharmaceuticals USA, Inc. v. [read post]
29 Jul 2022, 6:11 pm
Teva Pharmaceuticals USA, Inc., v. [read post]
30 Mar 2022, 7:56 am
Vizio, Inc., 2022 WL 885771 (Fed. [read post]
24 Feb 2022, 8:23 pm
Teva Pharmaceuticals USA, Inc., the panel majority affirming a District Court decision that the claimed invention was indeed obvious. [read post]
14 Feb 2022, 9:38 am
Teva Pharmaceuticals USA, Inc., 18-1976 (Fed. [read post]
23 Dec 2021, 8:48 pm
One such decision arose earlier this month when the Federal Circuit affirmed a determination of non-obviousness by the Patent Trial and Appeal Board in an inter partes review proceeding, that opinion captioned Teva Pharmaceuticals USA, Inc. v. [read post]
7 Dec 2021, 8:33 am
Inc. v. [read post]
24 Aug 2021, 2:10 am
USA Inc., No. 20-1630 (D. [read post]
5 Aug 2021, 12:12 pm
USA, Inc. v. [read post]
10 Feb 2021, 7:12 pm
Teva Pharmaceuticals USA, Inc. [read post]
